We focused on a set of high-confidence 103 direct p53 target genes, referred to as “core p53 targets”, which are induced upon MDM2 inhibition at the nascent RNA level in a p53-dependent manner across multiple cancer cell types [4]. This evidence concerns the gene MDM2 and cancer.